Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MTOR | P42345 | 20/20 | 0.72 |
| ▸ | CYP3A4 | P08684 | 5/20 | 0.72 |
| ▸ | RPTOR | Q8N122 | 5/20 | 0.54 |
| ▸ | MLST8 | Q9BVC4 | 5/20 | 0.54 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.53 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1836460 | 0.95 | MTOR (0.80) | MTORCYP3A4RPTORMLST8KCNH2 | |
| SCHEMBL1832621 | 0.89 | MTOR (0.90) | MTORCYP3A4RPTORMLST8KCNH2 | |
| SCHEMBL1832619 | 0.89 | MTOR (0.90) | MTORCYP3A4RPTORMLST8KCNH2 | |
| SCHEMBL1832490 | 0.88 | MTOR (0.71) | MTORCYP3A4RPTORMLST8KCNH2 | |
| SCHEMBL15189859 | 0.86 | MTOR (0.67) | MTORCYP3A4RPTORMLST8KCNH2 | |
| SCHEMBL1831561 | 0.85 | MTOR (0.85) | MTORCYP3A4RPTORMLST8KCNH2 | |
| SCHEMBL1831558 | 0.85 | MTOR (0.85) | MTORCYP3A4RPTORMLST8KCNH2 | |
| SCHEMBL1831003 | 0.85 | MTOR (0.66) | MTORCYP3A4RPTORMLST8KCNH2 | |
| SCHEMBL1831947 | 0.84 | MTOR (0.91) | MTORCYP3A4RPTORMLST8KCNH2 | |
| SCHEMBL1831945 | 0.84 | MTOR (0.91) | MTORCYP3A4RPTORMLST8KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2318377-A1 | PYRIMIDINE COMPOUNDS, COMPOSITIONS AND METHODS OF USE | Genentech, Inc. (US) | 2011-05-11 | — | — | EP | disclosed |
| WO-2010014939-A1 | PYRIMIDINE COMPOUNDS, COMPOSITIONS AND METHODS OF USE | GENENTECH, INC. (US) | 2010-02-04 | — | — | WO | disclosed |